Morgan Stanley raised the firm’s price target on Thermo Fisher (TMO) to $678 from $647 and keeps an Overweight rating on the shares, which the analyst also reinstated as a “Top Pick.” Q4 revenue and EPS came in modestly ahead of expectations, while 2025 guidance for 3%-4% organic growth, or 4%-5% excluding COVID contributions, “comes as a relief” following recent nerves given peer results and policy uncertainty, the analyst tells investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $690 from $630 at Bernstein
- Thermo Fisher price target raised to $693 from $689 at RBC Capital
- Thermo Fisher price target raised to $660 from $632 at Baird
- Thermo Fisher price target raised to $680 from $660 at Wells Fargo
- Thermo Fisher price target raised to $650 from $600 at Citi